-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - Summary of evidence (continued)
12
Key Question Outcome
Strength of
Evidence
Grade Conclusion … Summary of evidence (continued)
13
Key Question Outcome
Strength of
Evidence
Grade Conclusion … Summary of evidence (continued)
14
Key Question Outcome
Strength of
Evidence
Grade Conclusion … Summary of evidence (continued)
15
Key Question Outcome
Strength of
Evidence
Grade Conclusion … Risk assessment and risk mitigation strategies
(continued)
b.
-
effectivehealthcare.ahrq.gov/sites/default/files/module-iv-skills-for-successful-engagement.pdf
May 29, 2025 - AHRQ envisions ongoing relationships between its research institutions and stakeholders so
that continued … Speaker notes: The level of and opportunities for stakeholder involvement in the EHC Program
have continued
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-disposition-comments.pdf
March 31, 2025 - However, we urge the
continued inclusion and centering of gender-inclusive
language in future updates … However, we encourage the
continued exploration of alternative research designs,
such as community-based … Academy of
Breastfeeding
Medicine
Discussion and
Conclusions
Implications: Consider changing, Continued … randomized controlled trials
(RCTs) are not feasible in breastfeeding research, we
encourage the continued … We look forward to continued collaboration with the CDC
and other stakeholders to advance breastfeeding
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
August 01, 2018 - Summary of low-strength* evidence findings by intervention class (continued)
*All findings are low-strength … Interventions/comparators with insufficient strength of evidence (continued) Table B. … Interventions/comparators with insufficient strength of evidence (continued)
8 9
Category Drug Comparator … Interventions/comparators with insufficient strength of evidence (continued) may mask patterns of effectiveness
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
December 01, 2010 - Research gaps and ongoing studies in completed evidence-based reports (continued)
B-2
Study Name … Research gaps and ongoing studies in completed evidence-based reports (continued)
B-3
Study Name … Research gaps and ongoing studies in completed evidence-based reports (continued)
B-4
Study Name … Research gaps and ongoing studies in completed evidence-based reports (continued)
B-5
Study Name … Research gaps and ongoing studies in completed evidence-based reports (continued)
B-6
Study Name
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
January 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: June 2, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness and Safety of Insulin Delivery and
Glucose Monitoring Methods for Diabetes…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer.pdf
November 01, 2016 - worked best:
»- Included 11 or more hours of meeting
time with the trained provider.
»- Often included continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dot-plots-methods.pdf
October 01, 2021 - Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews
Methods Research Report
Developing and Piloting a Tool To Create Dot Plots To
Summarize Pooled Data for Multiple Outcomes in
Systematic Reviews
Methods Research Report
Developin…
-
effectivehealthcare.ahrq.gov/products/continuous-outcomes-quantitative-synthesis/methods
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.pdf
May 29, 2025 - 1
Table 1. Proportion of Beneficiaries With and Without Cancer Diagnosis Prior to First Biologics Order Among Beneficiaries Satisfying a Period of
Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, and Period of Continuous Enrollment, 2006-2009
Note: An asterisk (*) sign…
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.pdf
May 29, 2025 - 1
Table 1. Proportion of Beneficiaries With and Without Cancer Diagnosis Prior to First Biologics Order Among Beneficiaries Satisfying a Period of
Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, and Period of Continuous Enrollment, 2006-2009
Note: An asterisk (*) sign…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
January 01, 2023 - causing trouble with family and friends.
2
Term Definition
Alcohol-use disorder
(DSM-5)5 (continued … Continued to drink even though it was causing depression or anxiety, other
health problems, or memory … amounts of alcohol to achieve intoxication or
desired effect or
(b) markedly diminished effect with continued … or recreational activities are given up or
reduced because of alcohol use; or
(7) alcohol use is continued … physical or psychological problem that is likely to have been caused or
exacerbated by alcohol (e.g., continued
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
August 01, 2013 - Inclusion and exclusion criteria (continued)
Category Inclusion Criteria Exclusion Criteria
Interventions … Inclusion and exclusion criteria (continued)
Category Inclusion Criteria Exclusion Criteria
Comparators … Inclusion and exclusion criteria (continued)
Category Inclusion Criteria Exclusion Criteria
Other … Summary of findings for Key Question 2: Pharmacological or
food supplement interventions (continued … Summary of findings for Key Question 2: Psychological and
behavioral interventions (continued)
Outcome
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
October 01, 2021 - Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews
Methods Research Report
Developing and Piloting a Tool To Create Dot Plots To
Summarize Pooled Data for Multiple Outcomes in
Systematic Reviews
Methods Research Report
Developin…
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_maps.pdf
May 29, 2025 - Utilization of Sulfonylureas per 100 Diabetic Medicare Beneficiaries With Continuous Enrollment in Parts A and B FFS and Part D, by
Hospital Referral Region (HRR), 2006-2009
Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug Order, by HRR, 2006
Annual Util…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - ARBs for
essential hypertension (continued)
Key question Strength of
evidence Conclusions
Key … Characteristics and labeled indications of ACEIs and ARBs evaluated in this report (continued)
Drug … Characteristics and labeled indications of ACEIs and ARBs evaluated in this report (continued)
Drug … Characteristics of studies reporting LV mass/function outcomes (continued)
Study Agents
studied … ARBs
for essential hypertension (continued)
Key question Strength of
evidence Conclusions
e
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
March 01, 2011 - Continued from previous page
Variable Year Biguanides Insulins Sulfonylureas Thiazolidinediones
Gender
-
effectivehealthcare.ahrq.gov/sites/default/files/implementation-package-unhealthy-alcohol-use-final.pdf
September 01, 2018 - Continued alcohol use despite having persistent or recurrent social or interpersonal problems
caused … Use is continued despite knowledge of having a persistent or recurrent physical or psychological
problem … Markedly diminished effect with continued use of the same amount of alcohol
11. … CASE ONE CONTINUED:
Mrs. … Continued… Mr. Daniels states he often drinks 4-5 beers at night after work.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
December 11, 2012 - Antiplatelet therapy initiated
during a hospitalization for UA/NSTEMI and continued for long-term management … the time
of the PCI procedure
Initiated on
presentation and
continued … percutaneous
coronary intervention
(PCI) while receiving
eptifibatide, the
infusion should be
continued … for up to 18
to 24 hr after the
procedure
Initiated either
upstream or at the
time of PCI and
continued … receive half
the usual rate of
infusion
Initiated either
upstream or at the
time of PCI and
continued
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
January 01, 2019 - Definitely no Investigators state "Across each of these strata, there continued to be no significant … Definitely no Investigators state "Across each of these strata, there continued to be no significant